PEAR Annual FCF
-$117.36 M
-$3.69 M-3.25%
31 December 2022
Summary:
As of February 5, 2025, PEAR annual free cash flow is -$117.36 million, with the most recent change of -$3.69 million (-3.25%) on December 31, 2022. During the last 3 years, it has fallen by -$80.49 million (-218.26%).PEAR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PEAR Quarterly FCF
-$25.35 M
-$1.50 M-6.29%
31 December 2022
Summary:
As of February 5, 2025, PEAR quarterly free cash flow is -$25.35 million, with the most recent change of -$1.50 million (-6.29%) on December 31, 2022. Over the past year, it has increased by +$16.75 million (+39.78%).PEAR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PEAR TTM FCF
-$117.36 M
+$16.75 M+12.49%
31 December 2022
Summary:
As of February 5, 2025, PEAR TTM free cash flow is -$117.36 million, with the most recent change of +$16.75 million (+12.49%) on December 31, 2022. Over the past year, it has dropped by -$3.69 million (-3.25%).PEAR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PEAR Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.3% | +39.8% | -3.3% |
| 3 y3 years | -218.3% | - | - |
| 5 y5 years | -218.3% | - | - |
PEAR Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +218.3% | +16.6% | +439.6% |
Pear Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$117.36 M(+3.2%) | -$25.35 M(+6.3%) | -$117.36 M(-12.5%) |
| Sept 2022 | - | -$23.85 M(-23.0%) | -$134.11 M(-1.7%) |
| June 2022 | - | -$30.96 M(-16.8%) | -$136.47 M(+5.7%) |
| Mar 2022 | - | -$37.21 M(-11.6%) | -$129.13 M(+13.6%) |
| Dec 2021 | -$113.67 M | -$42.10 M(+60.7%) | -$113.67 M(+58.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$26.20 M(+10.9%) | -$71.57 M(+57.8%) |
| June 2021 | - | -$23.62 M(+8.6%) | -$45.37 M(+108.6%) |
| Mar 2021 | - | -$21.75 M | -$21.75 M |
| Dec 2020 | -$71.79 M(+94.7%) | - | - |
| Dec 2019 | -$36.88 M | - | - |
FAQ
- What is Pear Therapeutics annual free cash flow?
- What is the all time high annual FCF for Pear Therapeutics?
- What is Pear Therapeutics annual FCF year-on-year change?
- What is Pear Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Pear Therapeutics?
- What is Pear Therapeutics quarterly FCF year-on-year change?
- What is Pear Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Pear Therapeutics?
- What is Pear Therapeutics TTM FCF year-on-year change?
What is Pear Therapeutics annual free cash flow?
The current annual FCF of PEAR is -$117.36 M
What is the all time high annual FCF for Pear Therapeutics?
Pear Therapeutics all-time high annual free cash flow is -$36.88 M
What is Pear Therapeutics annual FCF year-on-year change?
Over the past year, PEAR annual free cash flow has changed by -$3.69 M (-3.25%)
What is Pear Therapeutics quarterly free cash flow?
The current quarterly FCF of PEAR is -$25.35 M
What is the all time high quarterly FCF for Pear Therapeutics?
Pear Therapeutics all-time high quarterly free cash flow is -$21.75 M
What is Pear Therapeutics quarterly FCF year-on-year change?
Over the past year, PEAR quarterly free cash flow has changed by +$16.75 M (+39.78%)
What is Pear Therapeutics TTM free cash flow?
The current TTM FCF of PEAR is -$117.36 M
What is the all time high TTM FCF for Pear Therapeutics?
Pear Therapeutics all-time high TTM free cash flow is -$21.75 M
What is Pear Therapeutics TTM FCF year-on-year change?
Over the past year, PEAR TTM free cash flow has changed by -$3.69 M (-3.25%)